Practice Patterns of Family Physicians With and Without Addiction Medicine Board Certification

References

1. 1.↵
   Centers for Disease Control and Prevention. Provisional Drug Overdose Death Counts. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Published 2020. Accessed August 4, 2020.
2. 2.↵
   Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). 2019. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Services Administration.
3. 3.↵
   Overdose Detection Mapping Application Program. The Consequences of COVID-19 on the Overdose Epidemic: Overdoses are Increasing. Available from: http://www.odmap.org/Content/docs/news/2020/ODMAP-Report-May-2020.pdf. Published 2020. Accessed August 4, 2020.
4. 4.↵
   1. Becker WC,
   2. Fiellin DA

   . When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med 2020;173(1):59–60.

   OpenUrlPubMed
5. 5.↵
   1. Slavova S,
   2. Rock P,
   3. Bush HM,
   4. Quesinberry D,
   5. Walsh SL

   . Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend 2020;214:108176.

   OpenUrl
6. 6.↵
   1. Edelman EJ,
   2. Oldfield BJ,
   3. Tetrault JM

   . Office-based addiction treatment in primary care: approaches that work. Med Clin 2018;102(4):635–652.

   OpenUrl
7. 7.↵
   1. Korthuis PT,
   2. McCarty D,
   3. Weimer M,
   4. et al

   . Primary care–based models for the treatment of opioid use disorder: A scoping review. Ann Intern Med 2017;166(4):268–278.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Wakeman SE,
   2. Pham-Kanter G,
   3. Donelan K

   . Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Subst Abus 2016;37(4):635–641.

   OpenUrl
9. 9.↵
   Survey Research Laboratory. Missed Opportunity: National Survey of Primary Care Physicians and Patients on Substance Abuse. Chicago, IL: University of Illinois at Chicago; 2000.
10. 10.↵
    1. Tong S,
    2. Sabo R,
    3. Aycock R,
    4. et al

    . Assessment of addiction medicine training in family medicine residency programs: a CERA study. Fam Med 2017;49(7):537.

    OpenUrl
11. 11.↵
    1. Peterson LE,
    2. Morgan ZJ,
    3. Borders TF

    . Practice predictors of buprenorphine prescribing by family physicians. J Am Board Fam Med 2020;33(1):118–123.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Peterson LE,
    2. Morgan ZJ,
    3. Eden AR

    . Early-Career and graduating physicians more likely to prescribe buprenorphine. J Am Board Fam Med 2020;33(1):7–8.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Abraham R,
    2. Wilkinson E,
    3. Jabbarpour Y,
    4. Petterson S,
    5. Bazemore A

    . Characteristics of office-based buprenorphine prescribers for Medicare patients. J Am Board Fam Med 2020;33(1):9–16.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Tong ST,
    2. Hochheimer CJ,
    3. Peterson LE,
    4. Krist AH

    . Buprenorphine provision by early career family physicians. Ann Fam Med 2018;16(5):443–446.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Nishiaoki M,
    2. McNally D,
    3. Bey RM,
    4. Arias AJ

    . New ACGME-accredited addiction medicine fellowship programs and their impact on the field. Curr Treat Options Psychiatry 2020;7(1):1–8.

    OpenUrl
16. 16.↵
    1. Kunz K,
    2. Wiegand T

    . Addiction medicine: current status of certification, maintenance of certification, training, and practice. J Med Toxicol 2016;12(1):76–78.

    OpenUrl
17. 17.↵
    American Board of Preventive Medicine. Addiction Medicine Requirements. Available from: https://www.theabpm.org/become-certified/subspecialties/addiction-medicine/. Published 2020. Accessed August 4, 2020.
18. 18.↵
    American Board of Preventive Medicine. The American Board of Preventive Medicine and the American Society of Addiction Medicine Announce a Four-Year Extension of the Practice Pathway for Addiction Medicine. Available from: https://www.theabpm.org/2020/11/30/the-american-board-of-preventive-medicine-and-the-american-society-of-addiction-medicine-announce-a-four-year-extension-of-the-practice-pathway-for-addiction-medicine/. Published 2020. Accessed December 9, 2020.
19. 19.↵
    1. Komaromy M,
    2. Duhigg D,
    3. Metcalf A,
    4. et al

    . Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders. Subst Abus 2016;37(1):20–24.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Brooklyn JR,
    2. Sigmon SC

    . Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact. J Addict Med 2017;11(4):286.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Peterson L,
    2. Fang B,
    3. Phillips R Jr.,
    4. Avant R,
    5. Puffer J

    . A certification board's tracking of their specialty: the American Board of Family Medicine's data collection strategy. J Am Board Fam Med 2019;32(1):89–95.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Weidner AKH,
    2. Chen FM,
    3. Peterson LE

    . Developing the National Family Medicine Graduate Survey. J Grad Med Educ 2017;9(5):570–573.

    OpenUrl
23. 23.↵
    1. Louis JS,
    2. Eden AR,
    3. Morgan ZJ,
    4. Barreto TW,
    5. Peterson LE,
    6. Phillips RL

    . Maternity care and buprenorphine prescribing in new family physicians. Ann Fam Med 2020;18(2):156–158.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Egan JE,
    2. Casadonte P,
    3. Gartenmann T,
    4. et al

    . The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med 2010;25(9):936–941.

    OpenUrlCrossRefPubMed